# Gut Permeability-related Inflammation and Cardiovascular Disease Risk in Normal-weight and Metabolically Healthy Obesity

> **NCT05308394** · — · UNKNOWN · sponsor: **Oklahoma State University** · enrollment: 80 (estimated)

## Conditions studied

- Obesity

## Interventions

- **OTHER:** No experimental intervention will take place - the study is cross-sectional. Each participant will provide biological samples.

## Key facts

- **NCT ID:** NCT05308394
- **Lead sponsor:** Oklahoma State University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-10
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308394, "Gut Permeability-related Inflammation and Cardiovascular Disease Risk in Normal-weight and Metabolically Healthy Obesity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05308394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*